InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Hernday Natasha. Insider active across 3 companies, notably XOMA Corp. In total, 7 filings have been recorded. Activity tracked since 15 May 2024. The latest transaction was filed on 11 June 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
Hernday Natasha is a declarant and is a Director at Janux Therapeutics, Inc., XOMA Royalty Corp and XOMA Corp. She has 4 filings in total, and the 4 sampled filings cover the period from 2024-05-17 to 2025-05-23, with the modal transaction nature shown as Attribution; the buy and sell amounts shown for this sample are 0 and 0.